Volume 13, Issue 2 pp. 196-200
Original Article
Full Access

Recurrent herpes simplex encephalitis: Recovery of virus after Ara-A treatment

Richard D. Dix PhD

Richard D. Dix PhD

Department of Neurology, University of California School of Medicine and the Veterans Administration Medical Center, San Francisco

Search for more papers by this author
J. Richard Baringer MD

Corresponding Author

J. Richard Baringer MD

Department of Neurology, University of California School of Medicine and the Veterans Administration Medical Center, San Francisco

Veterans Administration Medical Center, Salt Lake City, UT 84132Search for more papers by this author
Hillel S. Panitch MD

Hillel S. Panitch MD

Department of Neurology, University of California School of Medicine and the Veterans Administration Medical Center, San Francisco

Search for more papers by this author
Sidney H. Rosenberg MD

Sidney H. Rosenberg MD

Kaiser Permanente Medical Centers, Redwood City CA

Search for more papers by this author
Joel Hagedorn MD

Joel Hagedorn MD

Kaiser Permanente Medical Centers, Redwood City CA

Search for more papers by this author
Jay Whaley MD

Jay Whaley MD

Kaiser Permanente Medical Centers, South San Francisco, CA

Search for more papers by this author
First published: February 1983
Citations: 40

Abstract

A 54-year-old man developed clinical findings consistent with herpes simplex virus (HSV) encephalitis. These signs included an abrupt onset of focal central nervous system disease, cerebrospinal fluid pleocytosis, localized electroen cephalographic abnormalities, and a computerized tomographic scan showing right temporal lobe involvement. Treatment with adenine arabinoside (Ara-A) resulted in improvement. Two months later he again became confused, and a left hemiparesis developed. Although biopsy revealed extensive necrosis and inflammatory response, HSV antigens and herpesvirus particles were not detected. Culture of biopsy tissue yielded HSV type 1 only after 18 days. A second course of Ara-A was administered but the patient failed to improve and died four months later. Extensive inflammatory necrosis of both temporal lobes involving gray and white matter was found. Cultures were negative for HSV. The recovery of virus from our patient during the second encephalitic episode should raise concerns regarding the efficacy of Ara-A treatment and the role of the virus in recurrent disease. In addition, the importance of maintaining biopsy tissue in culture for prolonged periods is emphasized.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me